Management Team

Svein Mathisen, President and CEO
Master of Science, Engineering Physics. Lives  in
Malmö, Sweden. President and CEO since 1997. Previously
held senior positions within the Norsk Hydro Group. Member
of the Board since 2001.
Other board appointments: Chairman of the Board of Biotec
Pharmacon ASA and member of the Boards of Camurus AB
and SwedenBIO.
Shareholding: 1,050 000
Employee options: 24,000

Björn Frendéus, Vice President, Preclinical Research
Doctor of Immunology. Lives in Landskrona,
Sweden. Employed since 2001. Graduated as the nation's
first student from the Swedish Foundation for Strategic
Research funded Biomedicine programmes within the
Infection & Vaccinology programme in 2001.
Shareholding: 740 (own and affiliated holdings)
Employee options: 44,250

Cristina Glad, Executive Vice President
Doctor of Science, Biochemistry, MBA. Lives in
Malmö, Sweden. Employed in 1987 by the former subsidiary
Bioinvent Production AB. Member of the Royal Swedish
Academy of Engineering Sciences. Member of the Boards
of Ideonfonden AB and Lund University, Faculty of Medicine.
Shareholding: 1,043,301
Employee options: 24,000

Steven Glazer, Senior Vice President, Development
Doctor of Medicine. Lives in Copenhagen,
Denmark. Employed since 2004. 2001-2004 Medical
Director and Director of Development at Maxygen A/S,
Denmark. Previously employed at NovoNordisk A/S etc.
Shareholding: -
Employee options: 46,500

Per-Anders Johansson, Vice President, Quality Assurance and
Regulatory Affairs
Master of Science, Chemistry. Lives in Lund,
Sweden. Employed in 1984 by the former subsidiary
Bioinvent Production AB.
Shareholding: 250,000
Employee options: 24,000

Sten Westerberg, Vice President, Investor Relations
Lives in Bjärred, Sweden. Employed since 2011. 1995-2011 Sell-side analyst at Öhman Fondkomission and Swedbank Markets. 1993-95 Financial journalist at Veckans Affärer.
Shareholding: -
Employee options: 30,000

Martin Wiles, Senior Vice President, Business Development
Ph. D. Chemistry, MBA. Lives in London, Great
Britain. Employed since 2003. 1999-2003 Head of Business
Development at KS Biomedix Holdings Plc, listed on the
London Stock Exchange.
Shareholding: -
Employee options: 46,500